World's Best Scientists 2026 revealed!

D-Index & Metrics

Psychology

D-Index
66
Citations
17468
World Ranking
2692
National Ranking
1547

Overview

Sanjay J. Mathew is affiliated with Baylor College of Medicine in the United States. Their research spans medicine and neuroscience with a focus on pharmacology, cognitive neuroscience, biological psychiatry, experimental and cognitive psychology, and psychiatry and mental health.

The main topics of their work include:

  • Treatment of Major Depression
  • Functional Brain Connectivity Studies
  • Tryptophan and brain disorders
  • Mental Health Research Topics
  • Electroconvulsive Therapy Studies
  • Neurological disorders and treatments
  • Neural dynamics and brain function

They have contributed extensively to the academic literature with a focus on depression and neuropsychiatric treatments. Their frequent publication venues are:

  • Biological Psychiatry
  • Neuropsychopharmacology
  • The Journal of Clinical Psychiatry
  • American Journal of Psychiatry
  • Journal of Affective Disorders

Some of the recent papers they have been involved with include:

  • "Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression," 2023, New England Journal of Medicine
  • "A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedonia," 2020, Nature Medicine
  • "Deep Brain Stimulation for Depression Informed by Intracranial Recordings," 2021, Biological Psychiatry
  • "Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS)," 2020, Neuropsychopharmacology
  • "Efficacy of Esketamine Augmentation in Major Depressive Disorder," 2020, The Journal of Clinical Psychiatry

The scientist collaborates with several frequent co-authors, indicating a network of research partnerships. These include:

  • Wayne K. Goodman
  • James W. Murrough
  • Sameer A. Sheth
  • Dan V. Iosifescu
  • Anusha Allawala

Best Publications

  • Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial

    James W. Murrough;Dan V. Iosifescu;Lee C. Chang;Rayan K. Al Jurdi

  • Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression

    James W. Murrough;Andrew M. Perez;Sarah Pillemer;Jessica Stern

  • Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression.

    Rebecca B. Price;Rebecca B. Price;Matthew K. Nock;Dennis S. Charney;Sanjay J. Mathew

  • The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis

    Samuel T. Wilkinson;Elizabeth D. Ballard;Michael H. Bloch;Sanjay J. Mathew

  • Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression

    Marije aan het Rot;Katherine A. Collins;James W. Murrough;Andrew M. Perez

  • A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders.

    Gerard Sanacora;Mark A. Frye;William McDonald;Sanjay J. Mathew;Sanjay J. Mathew

  • Targeting glutamate signalling in depression: progress and prospects

    James W. Murrough;Chadi G. Abdallah;Sanjay J. Mathew

  • Neurobiological mechanisms in major depressive disorder

    Marije aan het Rot;Sanjay J. Mathew;Dennis S. Charney

  • Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)

    Maurizio Fava;Marlene P. Freeman;Martina Flynn;Heidi Judge

  • Ketamine for Depression: Where Do We Go from Here?

    Marije aan het Rot;Carlos A. Zarate;Dennis S. Charney;Sanjay J. Mathew;Sanjay J. Mathew

  • EFFECTS OF KETAMINE ON EXPLICIT AND IMPLICIT SUICIDAL COGNITION: A RANDOMIZED CONTROLLED TRIAL IN TREATMENT‐RESISTANT DEPRESSION

    Rebecca B. Price;Dan V. Iosifescu;James W. Murrough;Lee C. Chang

  • Ketamine for treatment-resistant unipolar depression: current evidence.

    Sanjay J. Mathew;Sanjay J. Mathew;Sanjay J. Mathew;Asim Shah;Kyle Lapidus;Crystal Clark;Crystal Clark

  • Novel drugs and therapeutic targets for severe mood disorders.

    Sanjay J Mathew;Husseini K Manji;Dennis S Charney

  • Amino Acid Neurotransmitters Assessed by Proton Magnetic Resonance Spectroscopy : Relationship to Treatment Resistance in Major Depressive Disorder

    Rebecca B. Price;Dikoma C. Shungu;Xiangling Mao;Paul Nestadt

  • Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression.

    C. N. Haile;J. W. Murrough;D. V. Iosifescu;L. C. Chang

  • Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression : a pilot randomized, placebo-controlled continuation trial

    Sanjay J. Mathew;James W. Murrough;Marije aan het Rot;Katherine A. Collins

  • Ketamine safety and tolerability in clinical trials for treatment-resistant depression.

    Le-Ben Wan;Cara F. Levitch;Andrew M. Perez;Jess W. Brallier

  • Neurobiology of anxiety disorders and implications for treatment.

    Amir Garakani;Sanjay J. Mathew;Dennis S. Charney

  • Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists.

    John H. Krystal;Sanjay J. Mathew;D. Cyril D’Souza;Amir Garakani

  • Neurobiological mechanisms of social anxiety disorder.

    Sanjay J. Mathew;Jeremy D. Coplan;Jack M. Gorman

  • Molecular targets in the treatment of anxiety

    Justine M Kent;Sanjay J Mathew;Jack M Gorman

Frequent Co-Authors

Jeremy D. Coplan
Jeremy D. Coplan SUNY Downstate Medical Center
Thomas C. Neylan
Thomas C. Neylan University of California, San Francisco
Boadie W. Dunlop
Boadie W. Dunlop Emory University
Leonard A. Rosenblum
Leonard A. Rosenblum SUNY Downstate Medical Center
Helen S. Mayberg
Helen S. Mayberg Icahn School of Medicine at Mount Sinai
Rebecca B. Price
Rebecca B. Price University of Pittsburgh
Elisabeth B. Binder
Elisabeth B. Binder Max Planck Society
Philip D. Harvey
Philip D. Harvey University of Miami
Barbara O. Rothbaum
Barbara O. Rothbaum Emory University
George I. Papakostas
George I. Papakostas Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

When exploring a career in psychology, it’s important to understand the variety of online degrees and career pathways available across the United States. Many students start by looking into regionally popular programs, which can provide insight into both educational quality and local demand for psychology professionals.

For example, those interested in urban environments may consider the popular psychology degrees in Las Vegas, while others might look at the most popular psychology degree programs in Nashville for a blend of southern culture and academic rigor.

Students seeking excellence in the Midwest can research top-ranked psychology degree programs in Oklahoma. Alternatively, those drawn to the Southeast will find that the best-ranked psychology degree programs in Orlando offer a wide range of opportunities, from clinical to organizational psychology.

By exploring these regional programs, prospective psychology students can choose an online degree that fits their needs and sets the foundation for successful careers in counseling, research, education, or mental health support.

Best Scientists Citing Sanjay J. Mathew

Trending Scientists

Recently Published Articles